CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research - Silvio E. Perea; Idania Baladron; Yanelda Garcia; Yasser Perera; Adlin Lopez; Jorge L. Soriano; Noyde Batista; Aley Palau; Ignacio Hernández; Hernán Farina; Idrian Garcia; Lidia Gonzalez; et al. (Molecular and Cellular Biochemistry, 2011)